Short interest in PharmaCyte Biotech Inc (NASDAQ:PMCB) increased during the last reporting period, rising from 21.05K to 61.68K. This put 1.39% of the company's publicly available shares short.

Short interest for PharmaCyte Biotech gives investors a sense of the degree to which investors are betting on the decline of PharmaCyte Biotech's stock. Short interest data is updated every two weeks.

Based on the recent average volume of 83.82K shares traded per day, it would take 1 day(s) for holders of this short interest to close out their positions without sending the stock sharply higher.